Bardo Schettini Gherardini

By Dr. Anne Pritchett The United States is the global leader in biopharmaceutical innovation. This leadership is built on the pillars of strong intellectual property protection, substantial investment in research and development (R&D), and a robust innovation ecosystem. These factors, combined with a market-based system that supports competitive drug pricing, encourage innovation and

By Chris Borges   Although patents are territorial, meaning they are limited to the jurisdiction in which they are granted, the networks spanning innovation and commerce are global. U.S. inventors routinely seek patent protection in markets abroad to safeguard their innovations, facilitate exports, and access new customers. By requiring member states

By Chris Borges As debates over trade balances intensify, policymakers should remember where the United States already excels: the creation, sale, and licensing of intellectual property (IP). IP rights such as patents, copyrights, and trademarks convert ideas into protected and transferable economic assets, promoting innovation and economic growth.